β-Lactamase Inhibitors
β-Lactamase Inhibitors
β-lactamase inhibitors potentiate /
reestablish the antibacterial potency of penicillinase sensitive penicillins
against β lactamase producing organisms by
inhibiting the enzyme. These are structurally similar to penicillin and act as
substitutes for penicillinase, causing inhibition of the enzyme.
These drugs have poor antimicrobial activity. They
are inhibitors of bacterial beta-lactamase. (Suicidal inhibition). They
are potent inhibitors of many bacterial beta-lactamases and can protect
hydrolyzable penicillins from inactivation by these enzymes. They are included
in combination with amoxacillin (Augmentum) or with ticaricillin. In particular,
clavulanic acid is an irreversible, "suicide" inhibitor of
beta-lactamase. (Potentiated penicillins)
e.g. Clavulanic
Acid, Sulbactam and Tazobactam
Clavulanic
acid
Obtained
from S. clavuligerus, has no antibacterial activity of its own. Generally combined
with Amoxicillin (2:1) or Ticarcillin (15:1)
Sulbactam
A
semi-synthetic penicillinase inhibitor related chemically and in activity to
clavulanic acid. Combined with ampicillin and preferably for oral and
pareneteral admn.
Tazobactam
Similar to sulbactam and
combined with piperacillin.
Penicillins with
sulbactam and tazobactam are administered IV; whereas, those with clavulanic
acid are administered orally or IV.
They are
available only in fixed combinations with specific penicillins:
Ampicillin + sulbactam
Amoxicillin + clavulanic acid
Ticarcillin + clavulanate potassium
Piperacillin + tazobactam sodium
Comments
Post a Comment